105.
Mischak H, Kolch W, Aivaliotis M, Bouyssie D, Court M, Dihazi H, Dihazi GH, Franke J, Garin J, de Peredo AG, Iphoefer A, Jänsch L, Lacroix C, Makridakis M, Masselon C, Metzger J, Monsarrat B, Mrug M, Norling M, Novak J, Pich A, Pitt A, Bongcam-Rudloff E, Siwy J, Suzuki H, Thongboonkerd V, Wang L, Zoidakis J, Zuerbig P, Schanstra J, Vlahou A
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.
Proteomics Clinical Applications 2010; 4:464-478
         
View Abstract       Request Reprint

104.
Griner EM, Caino MC, Sosa MS, Colon-Gonzalez F, Chalmers MJ, Mischak H, Kazanietz MG
A novel cross-talk in diacylglycerol signaling: the Rac-GAP {beta}2-chimaerin is negatively regulated by PKC{delta} mediated phosphorylation.
J Biol Chem. 2010 May 28;285(22):16931-41
         
View Abstract     Request Reprint

 
103.
Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JHH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H , Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
Mol Cell Proteomics. 2010 Jul 8
         
View Abstract     Request Reprint

102.
Delles C, Schiffer E, von zur Muhlen C, Peter K, Rossing P, Parving HH, Dymott JA a, Neisius U, Zimmerli LUa, Snell-Bergeon JK, Maahs DM, Schmieder RE, Mischak H, Dominiczak AF
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 subjects
J Hypertension
         
View Abstract     Request Reprint 

 


101.
Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D’Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman R, Ioannidis JPA, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovsk G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra T, Weissinger E, Yamamoto T, Vlahou A
Recommendations for biomarker identification and qualification in clinical proteomics.
Science Translational Medicine Papers 2010
         
View Abstract     Request Reprint 

100.
Drube J, Zürbig P, Schiffer E, Lau E, Ure B, Glüer S, Kirschstein M, Pape L, Decramer S, Bascands JL, Schanstra JP, Mischak H, Ehrich JH.
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.
Pediatr Nephrol. 2010 Sep;25(9):1673-8
         
View Abstract     Request Reprint 

99.
Caubet C, Lacroix C, Decramer S, Drube J, Ehrich JHH, Mischak H, Bascands JL, Schanstra JP
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.
Pediatr Nephrol. 2010 Jan;25(1):27-35
         
View Abstract     Request Reprint 

98.
Schiffer E.
The 2nd annual oncology biomarkers conference.
Biomark Med. 2009 Apr;3(2):203-9.
         
View Abstract     Request Reprint 

97.
Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drueke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Horl WH, Jankowski J, Jorres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski G, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A
The role of EUTox in uremic toxin research.
Seminars in dialysis 2009 Jul-Aug; 22 (4): 323-328.
         
View Abstract     Request Reprint

96.
Vlahou A, Allmaier G, Attwood T, Bongcam-Rudloff E, Charonis A, Frokiaer J, Mischak H, Schanstra J, Spasovski G.
2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29-30 March 2009, Nafplio, Greece.
Proteomics Clin Appl. 2009 Sep;3(9):1017-22.
         
View Abstract     Request Reprint

95.
Zürbig P, Mischak H, Conrads S
Urinary proteome analysis for early diagnosis of diabetes and its complications /
Eiweißanalyse im Urin zur frühen Diagnose des Diabetes und seiner Komplikationen
Diabetes, Stoffwechsel und Herz, Heft 6, 2009 Jahrgang 18
         
View Abstract     Request Reprint 

94.
Weissinger EM, Zürbig P, Ganser A.
Proteomics studies after hematopoietic stem cell transplantation.
Methods Mol Biol. 2009;506:437-52
         
View Abstract     Request Reprint 

93.
Zürbig P, Schiffer E, Mischak H.
Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery
Methods Mol Biol. 2009;564:105-21
         
View Abstract     Request Reprint  

92.
Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D
Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
Clin Cancer Res. 2009 Aug 1;15(15):4935-43
         
View Publisher Website     Request Reprint  

91.
Dhillona AS, Yipa YY, Grindlay GJ, Pakaya JL, Dangers M, Hillmann M, Clark W, Pitte A, Mischak H, Kolch W
The C-terminus of RAF-1 acts as a 14-3-3-dependent activation switch
Cell Signal. 2009 Nov;21(11):1645-51
         
View Publisher Website     Request Reprint  

90.
Jankowski V, Giet M, Mischak H, Morgan M, Zidekm W, Jankowski J
Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system (review)
Br J Pharmacol 2009 Aug;157(7):1142-53
         
View Publisher Website     Request Reprint  

89.
Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon J, Mischak H
Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in ANCA associated Vasculitis
Mol Cell Proteomics. 2009 Oct;8(10):2296-307
         
View Publisher Website     Request Reprint  

88.
Mischak H, Espandiari P, Sadrieh N, Hanig J
Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using capillary electrophoresis coupled with mass spectrometry as a potential model for detection of drug-induced adverse effects
PROTEOMICS - Clinical Applications 2009
         
View Publisher Website     Request Reprint  



87.
Kistler A, Mischak H, Poster D, Dakna M, Wuthrich R, Serra A
Identification of a unique urinary biomarker profile in autosomal dominant polycystic kidney disease
Kidney Int. 2009 Jul;76(1):89-96
         
View Publisher Website     Request Reprint  



86.
Weissinger EM, Mischak H, Kontsendorn J, Hahn A, Hahn N, Morgan M, Ganser A
Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry
Mini Rev Med Chem. 2009 May;9(5):627-3
         
View Publisher Website     Request Reprint  



85.
Metzger J, Luppa PB, Good DM, Mischak H
Adapting mass spectrometry-based platforms for clinical proteomics applications: the capillary electrophoresis coupled mass spectrometry paradigm
Crit Rev Clin Lab Sci. 2009;46(3):129-52
         
View Publisher Website     Request Reprint  



84.
Drube J, Schiffer E, Mischak H, Kemper M, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JHH
Urinary proteome pattern in children with renal Fanconi syndrome
Nephrol Dial Transplant. 2009 Jul;24(7):2161-9. Epub 2009 Feb 18
         
View Abstract     Request Reprint  



83.
Dakna M, He Z, Yu WC, Mischak H, Kolch W
Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment
Journal of Chromatography B 2009, 877(13): 1250-1258
         
View Abstract     Request Reprint  



82.
Mischak H, Massy ZA, Jankowski J
Proteomics and uremia and renal disease
 Seminars in Dialysis 2009 Jul-Aug; 22(4):409-16. 
         
View Abstract     Request Reprint  



81.
Zürbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL, Schanstra JP.
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.
Proteomics. 2009 Apr;9(8):2108-17
         
View Abstract     Request Reprint  



80.
Schiffer E, Mischak H, Zimmerli LU
Proteomics in gerontology - current applications and future aspects
Gerontology. 2009;55(2):123-37. Epub 2009 Jan 9
         
View Abstract     Request Reprint  



79.
Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K
Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients
Journal of Proteome Research 2009, 8(1): 335-345
         
View Abstract     Request Reprint  



78.
Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, Mischak H, Rewers M
Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease
Diabetes, Technology and Therapeutics 2009, 11(1): 1-9
         
View Abstract     Request Reprint  



77.
Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra J, Dominiczak AF
Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments
Mass Spectrom Rev. 2009 Sep-Oct;28(5):703-24
         
View Abstract     Request Reprint  



76.
Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease
Journal of Proteome Research 2009, 8(1): 268-281
         
View Abstract     Request Reprint  



75.
Metzger J, Schanstra JP, Mischak H
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments
Anal Bioanal Chem. 2009 Mar;393(5):1431-42. Epub 2008 Aug 15
         
View Abstract     Request Reprint  



74.
Haubitz M, Mischak H, Julian BA, Novak J
Urinary Protein Patterns as a Diagnostic Tool for Patients with Immunoglobulin A Nephropathy
European Renal Disease - Touch Briefings 2007
         
View Abstract     Request Reprint  



73.
Vlahou A, Schanstra J, Frokiaer J, El Nahas M, Spasovski G, Mischak H, Domon B, Allmaier G, Bongcam-Rudloff E, Attwood T; On behalf of the European Kidney and Urine Proteomics Network
Establishment of a European Network for Urine and Kidney Proteomics
J Proteomics 2008, 71(4): 490-492
         
View Abstract     Request Reprint  



72.
Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP
Urine in clinical proteomics
Mol Cell Proteomics 2008, 7(10): 1850-1862
         
View Abstract     Request Reprint  



71.
Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, Brecht M, Jenoe P, Hall MN, Hager K, Manns MP, Hecker H, Ganser A, Doehner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease
Proc Natl Acad Sci (USA) 2008, 105(32): 11299-11304
         
View Abstract     Request Reprint  



70.
Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J
A bench to bedside view of uremic toxins
J Am Soc Nephrol. 2008, 19: 863-870
         
View Abstract     Request Reprint  



69.
Coon JJ, Zurbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
PROTEOMICS - Clinical Applications 2008, 2(7-8): 964-973
         
View Abstract     Request Reprint  



68.
Schiffer E, Mischak H, Vanholder RC
Exploring the uremic toxins using proteomic technologies
Contrib Nephrol. 2008, 160: 159-171
         
View Abstract     Request Reprint  



67.
Decramer S, Zurbig P, Wittke S, Mischak H, Bascands JL, Schanstra JP
Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy
Contrib Nephrol. 2008, 160: 127-141
         
View Abstract     Request Reprint  



66.
Zurbig P, Mischak H
Capillary electrophoresis coupled to mass spectrometry for biomarker discovery and diagnosis of kidney diseases
Contrib Nephrol. 2008, 160: 107-126
         
View Abstract     Request Reprint  



65.
Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM
The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy
PROTEOMICS - Clinical Applications 2008, 2(7-8): 997-1007
         
View Abstract     Request Reprint  



64.
Raedler T, Wittke S, Jahn H, Kössler A, Mischak H, Wiedemann K
Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results
Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(3): 673-678
         
View Abstract     Request Reprint  



63.
Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P
Proteomic Discovery and Evaluation of Urinary Biomarkers for Diabetes and Chronic Renal Disease
J Am Soc Nephrol. 2008, 19(7): 1283-1290
         
View Abstract     Request Reprint  



62.
Schiffer E, Mischak H, Theodorescu, Vlahou A
Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform
World Journal of Urology 2008, 26(1): 67-74
         
View Abstract     Request Reprint  



61.
Theodorescu D, Schiffer E, Bauer HW, Douwes F, Eichhorn F, Polley R, Schmidt T, Schöfer W, Zurbig P, Good DM, Coon JJ, Mischak H
Discovery and validation of urinary biomarkers for prostate cancer
PROTEOMICS - Clinical Applications 2008, 2(4): 556-570
         
View Abstract     Request Reprint  



60.
Mathivanan S, et al., Mischak H, et al., Zurbig P, Pandey A
Human Proteinpedia: A portal for sharing and integration of human protein data
Nature Biotechnology 2008, 26(2): 164-167
         
View Abstract     Request Reprint  



59.
Zimmerli LU, Schiffer E, Zurbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter K, Mischak H, Kolch W, Delles C, Dominiczak AF
Urinary proteomic biomarkers in coronary artery disease
Mol Cell Proteomics 2008, 7(2): 290-298
         
View Abstract     Request Reprint  



58.
Goodsaid F, Bandow JE, Mischak H
REPORT - Grand Rounds in Proteomics at the FDA (White Oak, Silver Spring, MD, USA, April 3, 2007)
PROTEOMICS - Clinical Applications 2007, 1: 1526-1531
         
View Abstract     Request Reprint  



57.
Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H
Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future
J Proteome Res. 2007, 6(12): 4549-4555
         
View Abstract     Request Reprint  



56.
Julian BA, Wittke S, Novak J, Good D, Coon JJ, Kellmann M, Zurbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera S, Wyatt R, Sykora J, Sladkova E, Hes O, Mischak H, Mc Guire B
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases
Electrophoresis 2007, 28(23): 4469-4483
         
View Abstract     Request Reprint  



55.
Schiffer E
Biomarkers for prostate cancer
World Journal of Urology 2007, 25(6): 557-562
         
View Abstract     Request Reprint  



54.
Vanholder R, Meert N, Schepers E, Glorieux G, Argiles A, Brunet P, Cohen G, Drueke T, Mischak H, Spasovski G, Massy Z, Jankowski J; for the European Uremic Toxin Work Group (EUTox)
Review on uraemic solutes II Variability in reported concentrations: causes and consequences
Nephrol Dial Transplant. 2007, 22(11): 3115-3121
         
View Abstract     Request Reprint  



53.
Geppert HG, Mischak H
Klinische Proteomanalyse zur effektiven Gesundheitsvorsorge
journal of preventive medicine 2007, 3(3+4): 330-337
         
View Abstract     Request Reprint  



52.
Geppert HG
Polypeptide zeigen pathologische Prozesse
Nachrichten aus der Chemie 2007, 55: 1020-1021
         
View Abstract     Request Reprint  



51.
Julian BA, Wittke S, Haubitz M, Zurbig P, Schiffer E, McGuire BM, Wyatt RJ, Novak J
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases
World Journal of Urology 2007, 35(5): 467-476
         
View Abstract     Request Reprint  



50.
Decramer S, Bascands JL, Schanstra JP
Non-invasive markers of ureteropelvic junction obstruction
World Journal of Urology 2007, 25(5): 457-465
         
View Abstract     Request Reprint  



49.
Theodorescu D, Mischak H
Mass spectrometry based proteomics in urine biomarker discovery
World J Urol. 2007, 25(5): 435-443
         
View Abstract     Request Reprint  



48.
Geppert HG, von zur Mühlen C, Mischak H
Proteomanalyse zur Erkennung und Therapieevaluierung der koronaren Herzkrankheit
journal of preventive medicine 2007, 3(2): 160-168
         
View Abstract     Request Reprint  



47.
Wittke S, Schiffer E, Bauer HW
Kapillarelektrophorese gekoppelte Massenspektrometrie zur Proteomanalyse: Eine innovative diagnostische Methode bei Prostata- und Blasenkrebs
Der Urologe 2007, 46(7): 733-739
         
View Abstract     Request Reprint  



46.
Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zurbig P, Kellmann M, Ganser A
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Blood 2007, 109(12): 5511-5519
         
View Abstract     Request Reprint  



45.
Sniehotta M, Schiffer E, Zurbig P, Novak J, Mischak H
CE - a multifunctional application for clinical diagnosis
Electrophoresis 2007, 28(9): 1407-1417
         
View Abstract     Request Reprint  



44.
Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, Mischak H
Advances in urinary proteome analysis and biomarker discovery
J Am Soc Nephrol. 2007, 18(4): 1057-1071
         
View Abstract     Request Reprint  



43.
Mischak H, Pantke U, Fliser D
Proteomanalyse zur Erkennung, Früherkennung und Therapieevaluierung der diabetischen Nephropathie
journal of preventive medicine 2007, 3(1): 28-35
         
View Abstract     Request Reprint  



42.
Ehrich J, Mischak A, Mischak H
Proteomanalyse
Österreichische Ärztezeitung 2007, 6: 49-53
         
View Abstract     Request Reprint  



41.
Frommberger M, Zurbig P, Jantos J, Krahn T, Mischak H, Pich A, Just I, Schmitt-Kopplin P, Schiffer E
Peptidomic analysis of rat urine using capillary electrophoresis coupled to mass spectrometry
PROTEOMICS - Clinical Applications 2007, 1: 650-660
         
View Abstract     Request Reprint  



40.
Mischak H, Julian BA, Novak A
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine
PROTEOMICS - Clinical Applications 2007, 1: 792-804
         
View Abstract     Request Reprint  



39.
Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JHH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, Neusuess C, Novak J, Peter K, Rossing K, Schanstra J, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, van Eyk JE, Yamamoto T
Clinical Proteomics: a need to define the field and to begin to set adequate standards
PROTEOMICS - Clinical Applications 2007, 1: 148-156
         
View Abstract     Request Reprint  



38.
Weissinger EM, Mischak H
Application of proteomics to posttransplantational follow-up
Methods Mol Med. 2007, 134: 217-228
         
View Abstract     Request Reprint  



37.
Schiffer E, Mischak H, Novak J
High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS
Proteomics 2006, 6(20): 5615-5627
         
View Abstract     Request Reprint  



36.
Mischak H
Hochauflösende Proteomanalyse aus Urin in der nicht invasiven Diagnostik von Tumoren und chronischen Erkrankungen
prevention and anti aging 2006, 2(4): 426-435
         
View Abstract     Request Reprint  



35.
Zurbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neususs C, Theodorescu D, Root KE, Ross MM, Mischak H
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation
Electrophoresis 2006, 27(11): 2111-2125
         
View Abstract     Request Reprint  



34.
Gwinner W, Rohde F, Mischak H
Proteome analysis as a noninvasive tool in transplant monitoring
Biomarkers 2006, May: May
         
View Abstract     Request Reprint  



33.
Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, Bascands JL, Schanstra JP
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis
Nat Med. 2006, 12(4): 398-400
         
View Abstract     Request Reprint  



32.
Weissinger EM, Mischak H, Ganser A, Hertenstein B
Value of proteomics applied to the follow-up in stem cell transplantation
Ann Hematol. 2006, 85(4): 205-211
         
View Abstract     Request Reprint  



31.
Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
Lancet Oncol. 2006, 7(3): 230-240
         
View Abstract     Request Reprint  



30.
Weissinger EM, Nguyen-Khoa T, Saltiel C, Buisson C, Walden M, Kaiser T, Mischak H, Drüeke TB, Lacour B, Massy ZA
Effects of oral vitamin C supplementation on oxidative stress and inflammation status in hemodialysis patients – Classical and proteomic assessment
Proteomics 2006, 6(3): 993-1000
         
View Abstract     Request Reprint  



29.
Thongboonkerd V, Cutillas PR, Unwin RJ, Schaub S, Nickerson P, Haubitz M, Mischak H, Nedelkov D, Kiernan U, Nelson RW
Proteomics of Human Urine
Thongboonkerd V (Ed.) 2006, Proteomics of Human Body Fluids: Principles, Methods, and Applications
         
View Abstract     Request Reprint  



28.
Walden M, Wittke S, Mischak H, Vanholder RC
Proteomics of human dialysate and ultrafiltrate fluids yielded by renal replacement therapy
Thongboonkerd V (Ed.) 2006, Proteomics of Human Body Fluids: Principles, Methods, and Applications
         
View Abstract     Request Reprint  



27.
Girolami M, Mischak H, Krebs R
Analysis of complex, multidimensional datasets
Drug Dicovery Today: Analytical technologies 2006, 3(1): 13-19
         
View Abstract     Request Reprint  



26.
Kolch W, Neususs C, Pelzing M, Mischak H
Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery
Mass Spectrom Rev. 2005, 24(6): 959-977
         
View Abstract     Request Reprint  



25.
Chalmers MJ, Mackay CL, Hendrickson CL, Wittke S, Walden M, Mischak H, Fliser D, Just I, Marshall AG
Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease
Anal Chem. 2005, 77(22): 7163-7171
         
View Abstract     Request Reprint  



24.
Weissinger EM, Hertenstein B, Mischak H, Ganser A
Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis
Expert Reviews In: Proteomics 2005, 2(5): 639-647
         
View Abstract     Request Reprint  



23.
Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, Haller H, Gwinner W
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients
Am J Transplant. 2005, 5(10): 2479-2488
         
View Abstract     Request Reprint  



22.
Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H
Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis
J Diabetes Complications. 2005, 19(4): 223-232
         
View Abstract     Request Reprint  



21.
Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
Kidney Int. 2005, 68(1): 193-205
         
View Abstract     Request Reprint  



20.
Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, Ross M, Eltze E, Bettendorf O, Wulfing C, Semjonow A
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine
Electrophoresis. 2005, 26(14): 2797-2808
         
View Abstract     Request Reprint  



19.
Fliser D, Wittke S, Mischak H
Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes
Electrophoresis. 2005, 26(14): 2708-2716
         
View Abstract     Request Reprint  



18.
Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
Kidney Int. 2005, 67(6): 2313-2320
         
View Abstract     Request Reprint  



17.
Kolch W, Mischak H, Pitt AR
The molecular make-up of a tumour: proteomics in cancer research
Clin Sci (Lond). 2005, 108(5): 369-383
         
View Abstract     Request Reprint  



16.
Wittke S, Mischak H, Walden M, Kolch W, Radler T, Wiedemann K
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches
Electrophoresis. 2005, 26(7-8): 1476-1487
         
View Abstract     Request Reprint  



15.
Hillman M, Mischak H
CE-MS as a Tool for Renal Disease Analysis and Biomarker Discovery Pace Setter
The worldwide newsletter for capillary electrophoresis (Beckman Coulter) 2005, 9(2): 1-5
         
View Article     Request Reprint  



14.
Walden M, Mischak H
Proteomanalyse mittels Kapillarelektrophorese-gekoppelter Massenspektrometrie - ein neues Routineverfahren in der klinischen Diagnostik?
Klinische Chemie Mitteilungen 2005, 36(5): 87-101
         
View Abstract     Request Reprint  



13.
Weissinger EM, Kaiser T, Meert N, De Smet R, Walden M, Mischak H, Vanholder RC
Proteomics: a novel tool to unravel the patho-physiology of uraemia
Nephrol Dial Transplant. 2004, 19(12): 3068-3077
         
View Abstract     Request Reprint  



12.
Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D
Proteomic analysis for the assessment of diabetic renal damage in humans
Clin Sci (Lond). 2004, 107(5): 485-495
         
View Abstract     Request Reprint  



11.
Kolch W, Mischak H, Chalmers MJ, Pitt A, Marshall AG
Clinical proteomics: a question of technology
Rapid Commun Mass Spectrom. 2004, 18(19): 2365-2366
         
View Abstract     Request Reprint  



10.
Kaiser T, Wittke S, Just I, Krebs R, Bartel S, Fliser D, Mischak H, Weissinger EM
Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use
Electrophoresis 2004, 25(13): 2044-2055
         
View Abstract     Request Reprint  



9.
Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM
Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation
Blood 2004, 104(2): 340-349
         
View Abstract     Request Reprint  



8.
Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Golovko I, Rupprecht HD, Haubitz M, Hecker H, Mischak H, Fliser D
Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes
Kidney Int. 2004, 65(6): 2426-2434
         
View Abstract     Request Reprint  



7.
Haubitz M, Fliser D, Haller H
Proteomanalyse – eine neue Perspektive für die klinische Diagnostik
Deutsches Ärzteblatt 2004, 101(21): A-1514 / B-1255 / C-1207
         
View Abstract     Request Reprint  



6.
Wittke S, Kaiser T, Mischak H
Differential polypeptide display: the search for the elusive target
J Chromatogr B Analyt Technol Biomed Life Sci. 2004, 803(1): 17-26
         
View Abstract     Request Reprint  



5.
Chalmers MJ, Kolch W, Emmett MR, Marshall AG, Mischak H
Identification and analysis of phosphopeptides
J Chromatogr B Analyt Technol Biomed Life Sci. 2004, 803(1): 111-120
         
View Abstract     Request Reprint  



4.
Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, Sundmacher A, Schlegelberger B, Kolch W, Mischak H
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry
Rapid Commun Mass Spectrom. 2004, 18(2): 149-156
         
View Abstract     Request Reprint  



3.
Weissinger EM, Mischak H
Proteom analysis applied towards early diagnosis of renal diseases and transplant-monitoring
Transplantationsmedizin 2004, 16: 2-9
         
View Abstract     Request Reprint  



2.
Kaiser T, Hermann A, Kielstein JT, Wittke S, Bartel S, Krebs R, Hausadel F, Hillmann M, Golovko I, Koester P, Haller H, Weissinger EM, Fliser D, Mischak H
Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids
J Chromatogr A. 2003, 1013(1-2): 157-171
         
View Abstract     Request Reprint  



1.
Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, Hausadel F, Hillmann M, Golovko I, Koester P, Haller H, Kaiser T, Mischak H, Weissinger EM
Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers
J Chromatogr A. 2003, 1013(1-2): 173-181
         
View Abstract     Request Reprint